Synthetic Biology: Global Markets

The global market for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate (CAGR) of 28.4% during the forecast period of 2021-2026.

Report Includes

• 30 data tables and 99 additional tables
• An up-to-date review and analysis of the global market for synthetic biology within the life science industry
• Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Evaluation and forecast the global synthetic biology market size, forecasted growth trends, and corresponding market share analysis by product type, end-user industry, and region
• Highlights of the current and future market potential for synthetic biology products and technologies, and areas of focus to forecast this market into various segments and sub-segments
• Description of core synthetic biology products, key enabling technologies, and identify commercial opportunities for product development and competitive strategies
• In-depth assessment of the synthetic biology industry structure, competitors review, and intellectual property landscape
• Information on synthetic biology industry M&A deals, development of commercially viable products and technologies, and other strategic alliances within the industry
• Patent review and analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene-editing industry
• Detailed profiles of about 185+ companies within synthetic biology industry. Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc., and Twist Bioscience

The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.

Report Includes

• 29 data tables and 100 additional tables
• An overview of the global markets for synthetic biology
• Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
• Description of core synthetic biology products i.e. synthetic genes, DNA parts, chassis organisms, and synthetic cells
• Information on enabling technologies such as DNA sequencing, oligonucleotides, specialty media, and bioinformatics
• Knowledge about enabled technologies including biofuels, specialty chemicals, diagnostics, pharmaceuticals, and agriculture
• Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape
• Assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
• Comprehensive profiles of leading companies in the industry, including Active Motif, Bayer AG, BASF AG, Cargill Inc., Dowdupont Inc., Glaxosmithkline Plc, Merck KGAA, Novartis Pharma AG, Pfizer Inc. and Thermo Fisher Scientific Inc.

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Report Includes

• An overview of the global markets for synthetic biology
• Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells
• Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics
• Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture 
• Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape
• Assessments of the products and technologies most commercially viable now and in the near future 
• Company profiles of major players in the market, including Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc., Synthetic and Genomics, Inc

The global synthetic-biology market reached nearly $3.9 billion in 2016 and should reach $11.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 24.0% through 2021.

Report Includes

• An overview of the global markets for synthetic biology.
• Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells
• Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics
• Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture 
• Analysis of the synthetic biology industry structure, competitors and intellectual property landscape
• An assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
• Profiles of major players in the industry

The global synthetic biology market reached nearly $2.1 billion in 2012 and $2.7 billion in 2013. This market is expected to grow to $11.8 billion in 2018 with a compound annual growth rate (CAGR) of 34.4% over the five-year period from 2013 to 2018.

Report Includes

• An overview of the global market for synthetic biology.
• Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Information on the applications for synthetic biology including specialty chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms.
• An assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
• Comprehensive profiles of leading companies in the industry.

The global value of the synthetic biology market reached $1.1 billion in 2010. It is expected to reach $1.6 billion in 2011 and it will further grow to $10.8 billion by 2016, increasing at a compound annual growth rate (CAGR) of 45.8.%.

• The global market for synthetic biology generated $233.8 million in 2008. This is expected to increase to $2.4 billion in 2013, for a compound annual growth rate (CAGR) of 59.8%.
• The chemicals and energy segment has the largest share of the market, worth $80.6 million in 2008. This should reach $1.6 billion in 2013, for a CAGR of 81.6%.
• The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013.